New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 16, 2014
04:55 EDTHZNP, HZNP, HZNPHorizon Pharma management to meet with Jefferies
Meetings to be held in San Diego/San Francisco July 23-24 hosted by Jefferies.
News For HZNP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 22, 2015
09:58 EDTHZNPOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Allison Transmission (ALSN) initiated with a Buy at Stifel... Avago (AVGO) initiated with a Buy at Mizuho... Blackstone (BX) initiated with a Positive at Susquehanna... Cellectis (CLLS) initiated with an Outperform at Oppenheimer... Cypress Semiconductor (CY) initiated with a Buy at Mizuho... Esperion (ESPR) initiated with a Sell at Chardan... H&R Block (HRB) initiated with an Overweight at Piper Jaffray... Horizon Pharma (HZNP) initiated with an Outperform at Leerink... M/A-COM (MTSI) initiated with a Buy at Goldman... Meritor (MTOR) initiated with a Hold at Stifel... Micron (MU) initiated with a Buy at Mizuho... Monster Worldwide (MWW) initiated with a Neutral at Piper Jaffray... NXP Semiconductors (NXPI) initiated with a Buy at Mizuho... National Storage (NSA) initiated with a Sector Weight at KeyBanc... ON Semiconductor (ON) initiated with a Buy at Mizuho... Qorvo (QRVO) initiated with a Buy at Goldman... SanDisk (SNDK) initiated with a Neutral at Mizuho... Sharps Compliance (SMED) initiated with a Buy at Stifel... Skyworks (SWKS) initiated with a Buy at Mizuho... StemCells (STEM) initiated with a Buy at Cantor... Synaptics (SYNA) initiated with a Buy at Mizuho... Synergy Pharmaceuticals (SGYP) initiated with a Buy at Canaccord... Texas Instruments (TXN) initiated with a Neutral at Mizuho... TriNet (TNET) initiated with a Neutral at Piper Jaffray... Vascular Biogenics (VBLT) initiated with a Buy at Roth Capital... Verifone (PAY) initiated with an Outperform at Imperial Capital... uniQure (QURE) initiated with an Outperform at Oppenheimer.
07:06 EDTHZNPHorizon Pharma initiated with an Outperform at Leerink
Subscribe for More Information
May 21, 2015
12:40 EDTHZNPHayman's Bass requests review of POZEN patents
Subscribe for More Information
May 19, 2015
07:26 EDTHZNPHorizon Pharma meeting takeaways support investment thesis, says UBS
Subscribe for More Information
May 15, 2015
10:01 EDTHZNPOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:05 EDTHZNPHorizon Pharma initiated with a Buy at Jefferies
Target $37.
May 14, 2015
10:56 EDTHZNPOptions with decreasing implied volatility
Subscribe for More Information
May 13, 2015
11:08 EDTHZNPOptions with decreasing implied volatility
Subscribe for More Information
06:47 EDTHZNPHorizon Pharma UCD treatment has upside potential, says Piper Jaffray
After surveying 16 physicians who treat patients with urea cycle disorders, Piper Jaffray sees "ample room" for further growth of Horizon Pharma's Ravicti. Piper believes its Ravicti estimates could prove conservative and reiterates an Overweight rating on Horizon with a $38 price target.
May 12, 2015
10:16 EDTHZNPOptions with decreasing implied volatility
Options with decreasing implied volatility: NDLS WTW FUEL AOL LC NLNK ZU CYBR ARWR HZNP
May 11, 2015
10:19 EDTHZNPFMR reports 11.4% passive stake in Horizon Pharma
Subscribe for More Information
10:17 EDTHZNPOptions with decreasing implied volatility
Subscribe for More Information
May 8, 2015
10:25 EDTHZNPOptions with decreasing implied volatility
Subscribe for More Information
07:05 EDTHZNPHorizon Pharma raises FY15 revenue guidance to $590M-$610M from $450M-$475M
Consensus $538.76M.
07:04 EDTHZNPHorizon Pharma reports Q1 adjusted EPS 22c, consensus 21c
Reports Q1 revenue $113.1M, consensus $104.19M.
06:16 EDTHZNPHorizon Pharma announces Pennsaid 2% patent litigation with Perrigo
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use